BioCatalystWatch
AYTUWorkspace / AYTU / OverviewCompany library
AYTU BIOPHARMA, INC logo

AYTU BIOPHARMA, INC

AYTU BIOPHARMA, INC (AYTU)

Featured programme · Cotempla XR-ODT

Price
Market cap
Next catalyst—
Cash

Chart & Events

Candle interval

Core Clinical

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Approved / commercial

Cotempla XR-ODT

Approved

PreINDP1P2P3FilingApproved
Metadate CD

Approved

PreINDP1P2P3FilingApproved
Karbinal ER

Approved

PreINDP1P2P3FilingApproved
EXXUA

5-HT1A

Approved

PreINDP1P2P3FilingApproved
MiOXSYS®

Approved

PreINDP1P2P3FilingApproved

History / paused

PKCβ

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AYTU PR & News

PR & News

AYTU SEC archive